A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease

医学 肺病 重症监护医学 慢性病 内科学
作者
COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators,Surya Prakash Bhatt,Ehsan Abadi,A. Anzueto,Sandeep Bodduluri,Richard Casaburi,Peter J. Castaldi,Michael Cho,Alejandro P. Comellas,Douglas Conrad,Jeffrey L. Curtis,Chandra Dass,Dawn L. DeMeo,Mark T. Dransfield,Raúl San Jośe Estépar,Eric L. Flenaugh,Marilyn G. Foreman,Spyridon Fortis,Arnav Gupta,MeiLan K. Han
出处
期刊:JAMA [American Medical Association]
卷期号:333 (24): 2164-2164 被引量:25
标识
DOI:10.1001/jama.2025.7358
摘要

Importance: Individuals at risk for chronic obstructive pulmonary disease (COPD) but without spirometric airflow obstruction can have respiratory symptoms and structural lung disease on chest computed tomography. Current guidelines recommend COPD diagnostic schemas that do not incorporate imaging abnormalities. Objective: To determine whether a multidimensional COPD diagnostic schema that includes respiratory symptoms and computed tomographic imaging abnormalities identifies additional individuals with disease. Design, Setting, and Participants: This cohort study included 2 longitudinal cohorts: the Genetic Epidemiology of COPD (COPDGene), which enrolled 10 305 participants between November 9, 2007, and April 15, 2011, with longitudinal follow-up through August 31, 2022; and the Canadian Cohort Obstructive Lung Disease (CanCOLD), which enrolled 1561 participants between November 26, 2009, and July 15, 2015, with follow-up through December 31, 2023. Exposure: Exposure included the new multidimensional COPD diagnostic schema, defined by (1) major diagnostic category: presence of the major criterion (airflow obstruction based on postbronchodilator forced expiratory volume in the first second of expiration [FEV1]/forced vital capacity ratio <0.70) and at least 1 of 5 minor criteria (emphysema or bronchial wall thickening on computed tomography, dyspnea, poor respiratory quality of life, and chronic bronchitis); or (2) minor diagnostic category: presence of least 3 of 5 minor criteria (which must include emphysema and bronchial wall thickening for individuals with respiratory symptoms potentially due to other causes). Main Outcomes and Measures: All-cause mortality, respiratory cause-specific mortality, exacerbations, and annualized change in FEV1. Results: Among 9416 adults in COPDGene (mean [SD] age at enrollment, 59.6 [9.0] years; 5035 [53.5%] were men; 3071 [32.6%] were Black; 6345 (67.4%) were White; 4943 [52.5%] currently smoked), 811 of 5250 individuals (15.4%) without airflow obstruction were newly classified as having COPD by minor diagnostic category, and 282 of 4166 individuals (6.8%) with airflow obstruction were classified as not having COPD. Reclassified individuals with a new COPD diagnosis had greater all-cause mortality (adjusted hazard ratio, 1.98; 95% CI, 1.67-2.35; P < .001) and respiratory-specific mortality (adjusted hazard ratio, 3.58; 95% CI, 1.56-8.20; P = .003), more exacerbations (adjusted incidence rate ratio, 2.09; 95% CI, 1.79-2.44; P < .001), and more rapid FEV1 decline (adjusted β = -7.7 mL/y; 95% CI, -13.2 to -2.3; P = .006) compared with individuals classified as not having COPD. Among individuals with airflow obstruction on spirometry, those no longer classified as having COPD based on this new diagnostic schema had outcomes similar to those without airflow obstruction. Among 1341 adults in CanCOLD, individuals newly classified as having COPD experienced more exacerbations (adjusted incidence rate ratio, 2.09; 95% CI, 1.25-3.51; P < .001). Conclusions and Relevance: A new COPD diagnostic schema integrating respiratory symptoms, respiratory quality of life, spirometry, and structural lung abnormalities on computed tomographic imaging newly classified some individuals as having COPD. These individuals had an increased risk of all-cause and respiratory-related death, frequent exacerbations, and rapid lung function decline compared with individuals classified as not having COPD. Some individuals with airflow obstruction without respiratory symptoms or evidence of structural lung disease were no longer classified as having COPD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
云为晓完成签到,获得积分10
刚刚
帅气yumin发布了新的文献求助10
刚刚
swaggy完成签到,获得积分10
刚刚
好好有宇宙完成签到 ,获得积分10
刚刚
h11的应助被是个狼火采纳,获得10
刚刚
徐徐完成签到 ,获得积分10
1秒前
1秒前
1秒前
Lucas的应助被青柳安采纳,获得10
1秒前
程天康发布了新的文献求助10
1秒前
核桃发布了新的文献求助10
1秒前
爱笑的山灵完成签到,获得积分10
2秒前
所所的应助被南山无梅落366采纳,获得10
2秒前
红红发布了新的文献求助10
2秒前
Zengjx完成签到,获得积分10
2秒前
顶真完成签到,获得积分10
2秒前
csdhdhsiuhihi完成签到,获得积分10
2秒前
3秒前
长情诗蕾发布了新的文献求助10
3秒前
Paz完成签到,获得积分10
3秒前
补丁完成签到,获得积分10
3秒前
猫ovo猫完成签到,获得积分10
3秒前
3秒前
Cynthia完成签到,获得积分10
4秒前
老实皮皮虾完成签到,获得积分10
4秒前
4秒前
无花果的应助被kk采纳,获得10
4秒前
lalala发布了新的文献求助10
5秒前
yuyaoren完成签到,获得积分10
5秒前
l1t发布了新的文献求助30
5秒前
5秒前
hoke发布了新的文献求助10
6秒前
PostGGBone完成签到 ,获得积分10
6秒前
6秒前
ws完成签到,获得积分10
6秒前
6秒前
loy发布了新的文献求助20
6秒前
7秒前
weixuefeng完成签到,获得积分20
7秒前
zhangte完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159633
求助须知:如何正确求助?哪些是违规求助? 9555145
关于积分的说明 21725138
捐赠科研通 7749593
什么是DOI,文献DOI怎么找? 3427281
关于科研通互助平台的介绍 2552345
邀请新用户注册赠送积分活动 2471619